Illumina Nears Win In Bid To Block BGI's DNA Product Sales

By Dorothy Atkins (May 11, 2020, 10:37 PM EDT) -- A California federal judge said Monday that he's inclined to grant Illumina's preliminary bid to block China-based BGI Genomics from selling DNA sequencing products accused of infringing its patents, while BGI argued that an injunction would give Illumina total control of DNA sequencing in the Unites States at a critical time....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!